# Study of Adalimumab in Patients With Axial Spondyloarthritis

> **NCT00939003** · PHASE3 · COMPLETED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 192 (actual)

## Conditions studied

- Axial Spondyloarthritis

## Interventions

- **BIOLOGICAL:** Adalimumab
- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** Open-label Adalimumab

## Key facts

- **NCT ID:** NCT00939003
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2011-02
- **Final completion:** 2013-08
- **Target enrollment:** 192 (ACTUAL)
- **Last updated:** 2014-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00939003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00939003, "Study of Adalimumab in Patients With Axial Spondyloarthritis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00939003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*